Our Team

Helping to save lives together

Management Team

Laura McIntosh, Ph.D.

Chief Executive Officer

Dr. Laura McIntosh joined Dymedso in 2021 as the Chief Executive Officer. She is a biotech R&D leader with over 15 years of experience in the development and commercialization of innovative...

Read More

Laura McIntosh, Ph.D.

Chief Executive Officer

Dr. Laura McIntosh joined Dymedso in 2021 as the Chief Executive Officer. She is a biotech R&D leader with over 15 years of experience in the development and commercialization of innovative biological products and services for human health and agriculture. She has significant expertise in driving science and product development strategies, managing academic and industrial scientific collaborations, and intellectual property creation and management. Laura was a Venture Partner at adMare Bioinnovations, where she focused on identifying compelling areas of strategic commercial opportunity and driving the creation and acceleration of new companies. Prior to that, she was the Vice President R&D at Concentric AG where she was responsible for the science and IP strategy in the development of commercially viable microbial-based products for the soil microbiome. As Vice President, Translational Research at Caprion Biosciences, she was responsible for the scientific integrity and oversight of all client-based proteomics projects and also co-led a large public-private personalized medicine project in the province of Quebec. Dr. McIntosh also held senior-level positions at Osprey Pharmaceuticals Ltd where she led the research and clinical trials of a platform of protein therapeutic drugs, and at ART Advanced Research Technologies where she was involved in the development and commercialization of an optical imaging device. After completing her doctorate in human anatomy and cell biology at the University of Manitoba, Dr. McIntosh was awarded an NSERC post-doctoral fellowship at the National Research Council of Canada. She has 28 peer reviewed publications and 4 patents.

Kim Anderson

PRESIDENT

Kim Anderson is President of Dymedso. She joined the company in January 2017 as Sales and Marketing director. With over 20 years of experience in sales, she has worked for multinational organizations...

Read More

Kim Anderson

PRESIDENT

Kim Anderson is President of Dymedso. She joined the company in January 2017 as Sales and Marketing director. With over 20 years of experience in sales, she has worked for multinational organizations in the dental industry including orthodontics, implantology and CAD/CAM technology. Ms. Anderson holds a bachelor’s degree in marketing and Communication from University of Montreal. Her sales successes were directly linked to her customer-oriented selling approach and her skills to establish effective strategies to facilitate the integration of innovative technologies to the dental workflow. She has won numerous sales awards such as representative of the year, highest sales growth and achievement of sales goals for 6 consecutive years. Her experience in customer management, combined with solid technical experience, has allowed her to work with a wide range of specialists as well as university faculties, hospitals, private dental offices and dental laboratories. She was invited to lecture at several conferences and training, including the undergraduate program at University of Montreal and continuous education program for Dentists and dental staff. Ms. Anderson worked for 4 years in sales at Ormco, a dental company specializing in orthodontic appliances (Orange, CA). She also held a sales position for 2 years at Nobel Biocare (Toronto, CA) and she served as Executive Sales Manager for Dentsply Sirona Implants (Waltham MA) from 2005 to 2016.

Yvon Robert

Co-founder and Head of Product Development

Yvon Robert graduated from the University of Sherbrooke in arts, science and physical education. He has been actively involved in sports and cultural organizations in the region, either...

Read More

Yvon Robert

Co-founder and Head of Product Development

Yvon Robert graduated from the University of Sherbrooke in arts, science and physical education. He has been actively involved in sports and cultural organizations in the region, either as president of the Quebec games or as an event organizer. For several years, he was responsible for physical education programs at the School Board and he assumed teaching duties at the University of Sherbrooke. He then became Marketing Director for the Winnipeg Jets Farm Club (AHL) in the American Hockey League. Two years later, he joined the marketing department of the Montreal Canadiens hockey club where he created LES CANADIENS Magazine and became its editor. In 1988, Mr. Robert incorporated Les Consultants C.O.R.P. Inc., an outsourcing company operating in the publishing world. In 2002, Louis Plante, a young Cystic Fibrosis patient, invented an acoustic device for clearing the airways, and joined Yvon Robert to incorporate Dymedso Inc. After several years of clinical trials and research in acoustics at the University of Sherbrooke, Dymedso launched in 2006 its first version of the Frequencer®, a medical device that uses acoustic waves at low frequencies to dislodge the mucus that accumulates in the lungs. In 2009, Mr. Robert took over the management of the company to further develop and market the product. It took 2 years of additional development, design and certifications to finally introduce updated Frequencer® versions in 2011. In 2020, Yvon Robert transitioned the role of President to Kim Anderson, in order to focus on the development of new Dymedso products.

Pierre Massicotte, CPA-CA, CFA, FCSI, Fi. ,Pl

Chief Financial Officer

Mr. Massicotte, graduated from the Université Laval (Québec) with a Bachelor’s degree in business administration and has a license in Accounting Science. He obtained the Chartered Accountant...

Read More

Pierre Massicotte, CPA-CA, CFA, FCSI, Fi. ,Pl

Chief Financial Officer

Mr. Massicotte, graduated from the Université Laval (Québec) with a Bachelor’s degree in business administration and has a license in Accounting Science. He obtained the Chartered Accountant designation in 1992 and he is a member of l’Ordre des comptable professionnels agréés du Québec. He obtained a Fellow of the Canadian Securities Institute in 1997 and holds the Chartered Financial Analyst (CFA) designation, issued by the Chartered Financial Analyst Institute, since 2000. Mr. Massicotte also passed the Partner, Directors and Senior Officer Course from the Canadian Securities Institute in 2005 and is a certified Financial Planner from l’Institut québécois de planification financière since 1996. Mr. Massicotte was awarded the Queen Elizabeth II Diamond Jubilee Medal in 2013. He has 30 years of experience including 23 in a management capacity for several public companies. Prior to joining the company, he was employed by a public manufacturing company as Vice-President, Finances. Prior to that employment, from 2006 to 2009 he was employed by Industrial Alliance Insurance and Financial Services Inc. (“IA”) and was acting as General Manager and Chief Financial Officer of one of IA subsidiary, a Canada-wide business specialized in the mutual fund distributions. From 2004 to 2006, he worked as Chief Financial Officer and Chief Compliance Officer, Vice-President, Finance, Administration and Compliance of another IA subsidiary, an investment fund manager and promoter. From 1997 to 2004, Mr. Massicotte was an executive for different subsidiaries of the Laurential Bank of Canada. From 1990 to 1997, he worked for an international audit firm.

Scientific Advisory Committee

Dr. Simon Phaneuf MD, MBA

Advisory Committee Chair

Dr. Phaneuf is the Chair of Dymedso’s Scientific Advisory Committee. He joined the company in February 2020 to assist in the next stages of development. A medical doctor with extensive clinical...

Read More

Dr. Simon Phaneuf MD, MBA

Advisory Committee Chair

Dr. Phaneuf is the Chair of Dymedso’s Scientific Advisory Committee. He joined the company in February 2020 to assist in the next stages of development. A medical doctor with extensive clinical and academic experience, he has also participated in several start-ups in medical and technological companies. Dr Phaneuf currently teaches medicine at Université Laval and is a former Clinical Professor of Medicine at Université de Sherbrooke. He specializes in Emergency Medicine, Sports and Exercise Medicine and Lifestyle Medicine. Throughout his career, he participated in numerous clinical trials and sat on the Ethics Board Committee at Charles LeMoyne Hospital for several years. He also developed several medical devices in the fields of emergency medicine and minimally invasive surgery and is co-author of several corresponding patents. These innovations are currently being used on a daily basis both in North America and in Europe. His experience as executive includes implementation of ISO 13485 for design and production of medical devices as well as quality control systems compliant with the Canadian Food Inspection Agency requirements. He has also sat on corporate boards and scientific advisory committees of both private and public companies. Dr Phaneuf holds an MD degree from Université de Montréal and a certificate of added competence in Emergency Medicine and in Sports and Exercise Medicine as well as an executive MBA from Université de Sherbrooke. He also happens to be the first physician in the Province of Québec to be certified by the American Board of Lifestyle Medicine.

Nauman Chaudary, MD

Nauman Chaudary, MD, is Professor of medicine and director of the adult cystic fibrosis center at Virginia Commonwealth University (VCU). He established VCU's first adult cystic fibrosis center and...

Read More

Nauman Chaudary, MD

Nauman Chaudary, MD, is Professor of medicine and director of the adult cystic fibrosis center at Virginia Commonwealth University (VCU). He established VCU's first adult cystic fibrosis center and under his leadership initiated "age appropriate care" into the program as recommended by the Cystic Fibrosis Foundation. He has advanced the knowledge and innovation in treatment of cystic fibrosis and has conducted research trials, presented, and published on the topic in national meetings and peer reviewed journals.

Sean Gilman, MD

Sean Gilman, MD, is a pulmonologist and director of the McGill University Health Center smoking cessation program. Prior to his return to McGill in 2012, he was instructor of medicine at Harvard...

Read More

Sean Gilman, MD

Sean Gilman, MD, is a pulmonologist and director of the McGill University Health Center smoking cessation program. Prior to his return to McGill in 2012, he was instructor of medicine at Harvard Medical School and a pulmonologist at Beth Israel Deaconess Medical Center where he developed a tobacco treatment program for patients and employees. He is currently working on expanding the reach and accessibility of tobacco dependence treatment for all Quebecers.

Kris Ides, Ph.D.

Kris Ides, PhD, is a physiotherapist at the University of Antwerp in Belgium. He works with the children’s hospital at the University of Antwerp within the Cystic Fibrosis Center. He also focuses...

Read More

Kris Ides, Ph.D.

Kris Ides, PhD, is a physiotherapist at the University of Antwerp in Belgium. He works with the children’s hospital at the University of Antwerp within the Cystic Fibrosis Center. He also focuses on COPD and post COVID-19 rehabilitation. He continues to work at the University of Antwerp in the CoSys laboratory as an affiliated researcher for the Laboratory of Experimental Medicine and Pediatrics (LEMP) research group. In this role his research focuses on the “novel” outcome measures for respiratory physical therapy.

Tee Guidotti, MD, MPH

Tee Guidotti, MD, MPH, is an international consultant in occupational and environmental health. He is the former chair of the Department of Environmental and Occupational Health at George Washington...

Read More

Tee Guidotti, MD, MPH

Tee Guidotti, MD, MPH, is an international consultant in occupational and environmental health. He is the former chair of the Department of Environmental and Occupational Health at George Washington University and director of the Division of Occupational Medicine and Toxicology in the medical school. He is board-certified in the United States in internal medicine, pulmonary medicine, and occupational medicine, and is a Fellow of the Royal College of Physicians of Canada. Dr. Guidotti is an American Thoracic Society Fellow and Fellow of the American Association for the Advancement of Science.

Ashwin Basavaraj, M.D.

Ashwin Basavaraj, MD, is an Assistant Professor of Medicine and Associate Director of the Bronchiectasis Program at NYU Grossman School of Medicine. He is Section Chief of Pulmonary, Critical Care...

Read More

Ashwin Basavaraj, M.D.

Ashwin Basavaraj, MD, is an Assistant Professor of Medicine and Associate Director of the Bronchiectasis Program at NYU Grossman School of Medicine. He is Section Chief of Pulmonary, Critical Care and Sleep Medicine at Bellevue Hospital Center in New York. Dr. Basavaraj's research interests include bronchiectasis and non-tuberculous mycobacterial disease, with a specific focus in airway clearance techniques. He has lectured internationally on the topic and has chaired multiple postgraduate courses and scientific symposia. Dr. Basavaraj is a fellow of the American Thoracic Society and the American College of Chest Physicians.